|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.41 USD | -3.22% |
|
-8.97% | -3.51% |
| 03-11 | Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing | MT |
| 03-11 | Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | US$297.47 | +23.87% | 15 | ||||||
| US$663.96 | +33.94% | 24 | ||||||
| US$609.82 | +23.73% | 31 | ||||||
| US$264.91 | +35.81% | 22 | ||||||
| US$103.82 | +49.1% | 33 | ||||||
| €55.42 | +40.99% | 20 | ||||||
| US$96.46 | +13.37% | 28 | ||||||
| US$93.05 | +28.08% | 20 | ||||||
| US$163.29 | +41.48% | 17 | ||||||
| CN¥275.61 | +52.64% | 21 | ||||||
| US$398.05 | +33.78% | 21 | ||||||
| €28.58 | +15.31% | 20 | ||||||
| US$136.05 | +11.98% | 19 | ||||||
| US$76.6 | +1.58% | 10 | ||||||
| US$119.56 | +33.4% | 16 | ||||||
| JP¥1,888.46 | +39.99% | 13 | ||||||
| US$48.43 | +31.56% | 14 | ||||||
| HK$9.985 | +0.86% | 2 | ||||||
| US$158.91 | +23.21% | 11 | ||||||
| CN¥81.93 | +47.38% | 5 | ||||||
| Average | 278.52 | +29.10% | 18 | ||||||
| Weighted average by Cap. | 359.9 | +31.92% | 24 |
- Stock Market
- Equities
- RMD Stock
- Sector ResMed, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition